Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment.

Yonwaba Mzizi, Saidon Mbambara, Boitumelo Moetlhoa, Johncy Mahapane, Sipho Mdanda, Mike Sathekge, Mankgopo Kgatle
{"title":"Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment.","authors":"Yonwaba Mzizi, Saidon Mbambara, Boitumelo Moetlhoa, Johncy Mahapane, Sipho Mdanda, Mike Sathekge, Mankgopo Kgatle","doi":"10.3389/fnume.2024.1469897","DOIUrl":null,"url":null,"abstract":"<p><p>Ionising radiation (IR) is a form of energy that travels as electromagnetic waves or particles. While it is vital in medical and occupational health settings, IR can also damage DNA, leading to mutations, chromosomal aberrations, and transcriptional changes that disrupt the functions of certain cell regulators, genes, and transcription factors. These disruptions can alter functions critical for cancer development, progression, and treatment response. Additionally, IR can affect various cellular proteins and their regulators within different cell signalling pathways, resulting in physiological changes that may promote cancer development, progression, and resistance to treatment. Understanding these impacts is crucial for developing strategies to mitigate the harmful effects of IR exposure and improve cancer treatment outcomes. This review focuses on specific genes and protein biomarkers regulated in response to chronic IR exposure, and how their regulation impacts disease onset, progression, and treatment response.</p>","PeriodicalId":73095,"journal":{"name":"Frontiers in nuclear medicine (Lausanne, Switzerland)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532091/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in nuclear medicine (Lausanne, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fnume.2024.1469897","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Ionising radiation (IR) is a form of energy that travels as electromagnetic waves or particles. While it is vital in medical and occupational health settings, IR can also damage DNA, leading to mutations, chromosomal aberrations, and transcriptional changes that disrupt the functions of certain cell regulators, genes, and transcription factors. These disruptions can alter functions critical for cancer development, progression, and treatment response. Additionally, IR can affect various cellular proteins and their regulators within different cell signalling pathways, resulting in physiological changes that may promote cancer development, progression, and resistance to treatment. Understanding these impacts is crucial for developing strategies to mitigate the harmful effects of IR exposure and improve cancer treatment outcomes. This review focuses on specific genes and protein biomarkers regulated in response to chronic IR exposure, and how their regulation impacts disease onset, progression, and treatment response.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
电离辐照诱导的特定生物标志物调控及其对癌症和治疗的影响。
电离辐射(IR)是一种以电磁波或粒子形式传播的能量。电离辐射在医疗和职业健康领域非常重要,但它也会损伤 DNA,导致突变、染色体畸变和转录变化,从而破坏某些细胞调节因子、基因和转录因子的功能。这些干扰会改变对癌症发展、恶化和治疗反应至关重要的功能。此外,红外还能影响不同细胞信号通路中的各种细胞蛋白及其调节因子,从而导致生理变化,这些变化可能会促进癌症的发展、恶化和抗药性。了解这些影响对于制定减轻红外暴露有害影响和改善癌症治疗效果的策略至关重要。这篇综述将重点讨论特定基因和蛋白质生物标志物对慢性红外暴露的调控,以及它们的调控如何影响疾病的发生、发展和治疗反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
0
期刊最新文献
Case Report: All that glitters is not cancer; perihepatic hibernoma with fluctuating FDG uptake on PET/CT. Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment. Copper-61 is an advantageous alternative to gallium-68 for PET imaging of somatostatin receptor-expressing tumors: a head-to-head comparative preclinical study. Terbium sisters: current development status and upscaling opportunities. Mixture prior distributions and Bayesian models for robust radionuclide image processing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1